1. Home
  2. ARVN vs HIPO Comparison

ARVN vs HIPO Comparison

Compare ARVN & HIPO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Arvinas Inc.

ARVN

Arvinas Inc.

HOLD

Current Price

$8.95

Market Cap

658.2M

Sector

Health Care

ML Signal

HOLD

Logo Hippo Holdings Inc.

HIPO

Hippo Holdings Inc.

HOLD

Current Price

$25.78

Market Cap

737.1M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
ARVN
HIPO
Founded
2015
2015
Country
United States
United States
Employees
N/A
540
Industry
Biotechnology: Pharmaceutical Preparations
Property-Casualty Insurers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
658.2M
737.1M
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
ARVN
HIPO
Price
$8.95
$25.78
Analyst Decision
Buy
Buy
Analyst Count
19
3
Target Price
$15.05
$38.67
AVG Volume (30 Days)
858.9K
114.1K
Earning Date
05-04-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
58.84
N/A
EPS
N/A
N/A
Revenue
$262,600,000.00
N/A
Revenue This Year
N/A
$28.28
Revenue Next Year
N/A
$22.33
P/E Ratio
N/A
$7.64
Revenue Growth
N/A
N/A
52 Week Low
$6.06
$22.88
52 Week High
$14.22
$38.98

Technical Indicators

Market Signals
Indicator
ARVN
HIPO
Relative Strength Index (RSI) 37.05 41.88
Support Level $8.72 $24.81
Resistance Level $10.18 $26.82
Average True Range (ATR) 0.47 0.81
MACD 0.00 -0.09
Stochastic Oscillator 28.82 19.07

Price Performance

Historical Comparison
ARVN
HIPO

About ARVN Arvinas Inc.

Arvinas Inc is a clinical-stage biotechnology company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies that degrade disease-causing proteins. The company is using its PROteolysis TArgeting Chimera, a protein degradation platform, to develop therapeutics designed to harness the body's own natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins. Its clinical development program includes various product candidates such as ARV-102, ARV-806, ARV-393, ARV-027, and vepdegestrant, in their different stages of development, being developed to target certain harmful proteins causing oncology and neurology-related diseases.

About HIPO Hippo Holdings Inc.

Hippo Holdings Inc is a home insurance group that created a new standard of care and protection for homeowners. It provides insurance for computers, home offices, electronics, appliances, water backup, and service line coverage, among others. It has three reportable segments Services segment earns fees and commission income without assuming underwriting risk or need for reinsurance, Insurance-as-a-Service managed through the company's subsidiary Spinnaker is a platform to support third-party MGAs, and the Hippo Home Insurance Program engaged in homeowners insurance business. It generates the majority of its revenue from the Insurance-as-a-Service segment.

Share on Social Networks: